BIOMAT Database Logo BIOMAT Database Logo

Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children. 1998

N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
National Public Health Institute, Department in Turku, Finland. tranminh@utu.fi

235 healthy 10-12 years old school children were randomly immunized with either a booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) vaccine. For this booster immunization designed for school children and adults, the quantities of Bordetella pertussis antigens in the dTap vaccine had been reduced to one third of those of the Infanrix vaccine (SmithKline Beecham) commonly used for infants. IgG antibodies and cell-mediated immune (CMI) responses to pertussis toxin (PT), pertactin (PRN) and filamentous hemagglutinin (FHA) were assessed by an enzyme immunosorbent assay and in vitro proliferation of peripheral blood mononuclear cells, respectively. Before immunization, 55%, 80% and 99% of children had detectable serum IgG antibodies to PT, PRN and FHA, whereas CMI response was found in 35%, 27% and 50% of children, respectively. After immunization, a 20-30-fold increase in geometric mean level (GML) of antibodies to the pertussis antigens occurred and CMI response to PT, PRN and FHA was seen in 88%, 94% and 100% of children, respectively. Adverse reactions following the immunization were rare. The results show that booster immunization with an acellular pertussis vaccine with reduced concentrations of antigens induces both antibody and CMI responses and support further studies of this pertussis vaccine in school children.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D001886 Bordetella pertussis A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath. Bacterium tussis-convulsivae,Haemophilus pertussis,Hemophilus pertussis
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
September 2011, Vaccine,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.
August 1999, Infection and immunity,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.
December 2014, Clinical and vaccine immunology : CVI,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines.
April 1991, The Pediatric infectious disease journal,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults.
January 2016, Vaccine,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Acellular pertussis vaccine booster.
April 1993, Pediatrics,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
June 2000, The Journal of infectious diseases,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Adverse reactions and antibody responses to acellular pertussis vaccine.
December 1986, The Journal of pediatrics,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
September 2013, Clinical and vaccine immunology : CVI,
N N Tran Minh, and K Edelman, and Q He, and M K Viljanen, and H Arvilommi, and J Mertsola
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.
August 2004, The Journal of infectious diseases,
Copied contents to your clipboard!